Mirati Therapeutics reported $28.35M in Selling and Administration Expenses for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acceleron Pharma XLRN:US $ 31.06M 4.85M
Agios Pharmaceuticals AGIO:US $ 29.22M 4.34M
Alnylam Pharmaceuticals ALNY:US $ 154.9M 11.39M
Amgen AMGN:US $ 1.25B 519M
Astellas Pharma 4503:JP 137.11B 4.16B
AstraZeneca AZN:LN 2.57B 76M
Bayer BAYN:GR 3.52B 30M
Biocryst Pharmaceuticals BCRX:US $ 22.11M 1.13M
Bluebird Bio BLUE:US $ 86.87M 9.9M
Bristol Myers Squibb BMY:US $ 1.88B 215M
Eisai 4523:JP 70.04B 7.43B
Eli Lilly And LLY:US $ 1.58B 22.1M
Exelixis EXEL:US $ 102.35M 19.91M
Gilead Sciences GILD:US $ 1.34B 297M
GlaxoSmithKline GSK:LN 2.5B 183M
Johnson & Johnson JNJ:US $ 6.07B 641M
Merk MRK:US $ 2.25B 376M
Moderna Inc MRNA:US 77M 1.99M
Nektar Therapeutics NKTR:US $ 31.68M 4.54M
Novartis NOVN:VX 3.52B 388M
Pfizer PFE:US $ 2.79B 134M
Puma Biotechnology PBYI:US $ 28.24M 368K
Sarepta Therapeutics SRPT:US $ 71.13M 14.92M
Seattle Genetics SGEN:US $ 165.13M 5.29M
Spectrum Pharmaceuticals SPPI:US $ 28.63M 12.93M
Takeda 4502:JP 219.84B 14.55B
Ultragenyx Pharmaceutical RARE:US $ 53.26M 2.22M
YTE INCY:US $ 153.79M 13.19M